The pregnant woman with heart disease: Management of pregnancy and delivery

Netherlands Heart Journal

Volumn 20, Issue 1, 2012, Pages 33-37

  Pieper, P G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Delivery; Heart disease; Management; Pregnancy

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIVITAMIN K; ATENOLOL; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; OXYTOCIN;

ADULT; ANESTHESIA INDUCTION; AORTA SUBVALVULAR STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLEEDING; BRADYCARDIA; CARDIOVASCULAR RISK; CASE REPORT; CESAREAN SECTION; CLINICAL SUPERVISION; COMPRESSION GARMENT; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FLUID RETENTION; GESTATIONAL AGE; HEALTH CARE PERSONNEL; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE WALL MOTION; HEART RHYTHM; HEART SURGERY; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; MEDICAL HISTORY; PATIENT MONITORING; PREGNANT WOMAN; RISK ASSESSMENT; THROMBOEMBOLISM; WEIGHT GAIN;

EID: 84856244307     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0209-y     Document Type: Article

References (14)

1. Drenthen W, Boersma E, Balci A, On behalf of the ZAHARA investigators, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124-32.
2. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21.
3. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease. A literature review. J Am Coll Card. 2007;49(24):2302-11.
4. Pieper PG, Balci A, van Dijk AP. Pregnancy in women with prosthetic heart valves. Neth Heart J. 2008;16:406-11.
5. Pieper PG. Pre-pregnancy risk assessment and counselling of the cardiac patient. Neth Heart J 2011; Sep 7 (Epub ahead of print)
6. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011; Aug 26 (Epub ahead of print; doi:10.1093/eurheartj/ehr218)
7. Thorne S, McGregor A, Nelson-Piercy C. Risk of contraception and pregnancy in heart disease. Heart. 2006;92:1520-5.
8. CEMACH, London, 2007. Confidential enquiry into maternal and child health. Perinatal Mortality 2005: England, Wales and Northern Ireland.
9. Deanfield J, Thaulow E, Warnes C, et al. Management of grown up congenital heart disease. Eur Heart J. 2003;24:1035-84.
10. Newstead-Angel J, Gibson PS. Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications. Expert Rev Cardiovasc Ther. 2009;7:1569-80.
11. De Wilde JP, Rivers AW, Price DL. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Progr Biophys Mol Biol. 2005;87:335-53.
12. Yap SC, Drenthen W, Pieper PG, et al. On behalf of the ZAHARA Investigators. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol. 2008;126:240-6.
13. Balci A, Drenthen W, Mulder BJ, et al. Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J. 2011;161:307-13.
14. Fernandes SM, Arendt KA, Landsberg MJ, et al. Pregnant women with cardiac disease: cardiac, anesthetic and obstetrical implications. Expert Rev Cardiovasc Ther. 2010;8:439-48.